CONNECTA Therapeutics Secures €3.1M for Fragile X Program
BARCELONA, Spain — September 10, 2026 CONNECTA Therapeutics announced the closing of a €3.1 million financing led by new...
Biomarkers
Advertisement
Insilico Medicine Identifies Alzheimer’s Targets Using AI
Hong Kong, September 1, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), has announced...
Ono Pharma Partners With Aitia on Causal AI Drug Discovery
OSAKA, Japan and CAMBRIDGE, Mass., September 2, 2026 Ono Pharmaceutical Co., Ltd. has entered into a drug discovery partnership...
Agenus Reports Durable BOT+BAL Activity in MSS Colorectal Cancer
Lexington, Mass. – August 28, 2026 Agenus Inc. announced the publication of mature Phase 1b results evaluating botensilimab (BOT)...
Allies of Skin Launches Peptint Tripeptide Lip Treatment
Los Angeles, California, USA, August 21, 2026 Allies of Skin has announced the launch of Peptint Tripeptide & Goji...
Advertisements
AbbVie Highlights Lung Cancer Pipeline Data at WCLC 2026
North Chicago, Illinois, USA, August 21, 2026 AbbVie has announced new clinical, translational and real-world research findings that will...
Implantica Wins FDA Approval for RefluxStop® in U.S.
Stockholm, Sweden, August 21, 2026 Implantica AG has announced a major U.S. regulatory milestone after the U.S. Food and...
C2N PrecivityAD2 FDA Clearance Advances Alzheimer’s Testing
NEW YORK, August 21, 2026 The U.S. Food and Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2 blood test,...
Enhanced Group Launches AI-Powered Enhanced OS
New York, August 18, 2026 Enhanced Group, Inc. (NYSE: ENHA) has announced Enhanced OS, an AI-powered platform designed to...
Insilico Medicine Launches AI-Powered Virtual Aging Cell
Hong Kong, August 14, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), has...
Advertisement
